Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Oct 27;10(1):18374.
doi: 10.1038/s41598-020-75433-7.

Cardiovascular disease risk assessment in patients with familial Mediterranean fever related renal amyloidosis

Micol Romano  1   2 , David Piskin  3 , Roberta A Berard  1 , Bradley C Jackson  1 , Cengizhan Acikel  4 , Juan J Carrero  5 , Helen J Lachmann  6 , Mahmut I Yilmaz  7 , Erkan Demirkaya  8   9
Affiliations

Cardiovascular disease risk assessment in patients with familial Mediterranean fever related renal amyloidosis

Micol Romano et al. Sci Rep. .

Abstract

Chronic inflammation and proteinuria is a risk factor for cardiovascular disease (CVD) in patients with chronic kidney diseases and rheumatologic disorders. Our aim was to investigate the CVD events (CVDEs) and survival between the patients with FMF-related AA amyloidosis and glomerulonephropathies (GN) to define possible predictors for CVDEs. A prospective follow-up study with FMF-amyloidosis and glomerulonephropathy (GN) was performed and patients were followed for CVDEs. Flow-mediated dilatation (FMD), FGF-23, serum lipid, hsCRP levels, BMI and HOMA were assessed. A Cox regression analysis was performed to evaluate the risk factors for CVDEs. There were 107 patients in the FMF-amyloidosis group and 126 patients with GN group. Forty-seven CVDEs were observed during the 4.2-years follow up; all 28 patients in the FMF-amyloidosis group and 14/19 patients with GN developed CVDEs before the age of 40 (p = 0.002). CVD mortality was 2.8 times higher (95% CI 1.02-7.76) in patients with FMF-amyloidosis. Across both groups, FMD and FGF23 (p < 0.001) levels were independently associated with the risk of CVDEs. Patients with FMF-amyloidosis are at increased risk of early CVDEs with premature mortality age. FGF 23, FMD and hsCRP can stratify the risk of early CVD in patients with FMF-related AA amyloidosis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Flow diagram of patient selection for the study.
Figure 2
Figure 2
Comparison of cardiovascular disease survival between patients with FMF-related amyloidosis or glomerulonephropathy.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Ozen S, Demirkaya E, Erer B, et al. EULAR recommendations for the management of familial Mediterranean fever. Ann. Rheum. Dis. 2016;75(4):644–651. doi: 10.1136/annrheumdis-2015-208690. - DOI - PubMed
    1. Consortium IF Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell. 1997;90(4):797–807. doi: 10.1016/S0092-8674(00)80539-5. - DOI - PubMed
    1. Demirkaya E, Erer B, Ozen S, et al. Efficacy and safety of treatments in familial Mediterranean fever: A systematic review. Rheumatol. Int. 2016;36(3):325–331. doi: 10.1007/s00296-015-3408-9. - DOI - PubMed
    1. Erer B, Demirkaya E, Ozen S, et al. What is the best acute phase reactant for familial Mediterranean fever follow-up and its role in the prediction of complications? A systematic review. Rheumatol. Int. 2016;36(4):483–487. doi: 10.1007/s00296-015-3413-z. - DOI - PubMed
    1. Hull KM, Kastner DL, Balow JE. Hereditary periodic fever. New Engl. J. Med. 2002;346(18):1415–1416. doi: 10.1056/NEJM200205023461819. - DOI - PubMed

Publication types